Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04839003
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2021-03-22
Brief Title:
A Registry of AL Amyloidosis ReAL
Sponsor:
Fondazione IRCCS Policlinico San Matteo di Pavia
Organization:
Fondazione IRCCS Policlinico San Matteo di Pavia
Study Overview
Official Title:
A Registry to Investigate Real-world Natural History Impact of Therapies and Patterns of Progression of AL Amyloidosis ReAL
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ReAL
Brief Summary:
The purpose of this protocol is to generate a large registry of patients with AL amyloidosis
Detailed Description:
Thanks to this registry it will be possible to collect data at diagnosis and during follow up in order to be able to describe the natural history of AL amyloidosis in a real-world setting and to define and validate prognostic models response and relapse criteria applicable at any point of the disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None